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We synthesised and toxicologically characterised the arsenic metabolite thiodimethylarsinic acid (thio-DMAV). Successful
synthesis of highly pure thio-DMAV was confirmed by state-of-the-art analytical techniques including 1H-NMR, HPLC-FTMS,
and HPLC-ICPMS. Toxicological characterization was carried out in comparison to arsenite and its well-known trivalent and
pentavalent methylated metabolites. It comprised cellular bioavailability as well as diﬀerent cytotoxicity and genotoxicity end
points in cultured human A549 lung cells. Of all arsenicals investigated, thio-DMAV exerted the strongest cytotoxicity. Moreover,
thio-DMAV did not induce DNA strand breaks and an increased induction of both micronuclei and multinucleated cells occurred
only at beginning cytotoxic concentrations, indicating that thio-DMAV does not act via a genotoxic mode of action. Finally, to
assess potential implications of thio-DMAV for human health, further mechanistic studies are urgently necessary to identify the
toxic mode of action of this highly toxic, unusual pentavalent organic arsenical.
1. Introduction
Inorganic arsenic is a well-documented human carcino-
gen (IARC, Group 1) causing tumors in the lung, skin,
and bladder [1, 2]. However, the underlying molecular
mechanisms of inorganic arsenic-induced carcinogenicity
are still to be elucidated, especially since inorganic arsenic,
unlike other classical chemical carcinogens, does neither
induce direct DNA damage nor mutagenicity at exposure-
relevant concentrations [3]. Besides the contribution of its
metabolism, a variety of further potential mechanisms are
discussed, including the induction of genetic damage via
oxidative mechanisms [4–6], epigenetic dysregulation [7],
and interaction with the cellular DNA damage response and
DNA repair [8], resulting in comutagenic and cocarcinogenic
eﬀects [9].
For the general population, human diet is the primary
source of both total arsenic and inorganic arsenic intake.
The European Food Safety Authority (EFSA) Panel on
Contaminants in the Food Chain and the Joint Food
and Agriculture Organization/World Health Organisation
(FAO/WHO) Expert Committee on Food Additives (JECFA)
have concluded in their recent scientific opinions on arsenic
that risks to human health related to the presence of
inorganic arsenic in food cannot be excluded. In 2010,
the JECFA withdrew the previous provisional tolerable
weekly intake (PTWI) [9–11]. Furthermore, the EFSA Panel
emphasized the necessity for toxicological characterization of
seafood and fish-related organic arsenicals, including arseno-
sugars and arsenolipids, for which to date no toxicological
data exist [9]. In contrast to arsenobetaine, which is the
main arsenic compound in fish, but is not metabolized
by humans, arsenosugars and arsenolipids are extensively
biotransformed to a multitude of arsenic metabolites [12,
13]. Some of these compounds are believed to be highly toxic
and thus it cannot be excluded that seafood and fish-related
organic arsenic species present risks to human health.
Regarding in vitro toxicity of the well-known and part-
ly toxicologically characterised human inorganic arsenic
metabolites monomethylarsinous (MMAIII), dimethylarsi-
nous (DMAIII), monomethylarsonic (MMAV), and dimethy-
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larsinic (DMAV) acid, the trivalent metabolites exert
stronger cytotoxicity, as well as direct and indirect geno-
toxicity as compared to arsenite [14–21] in most cellu-
lar and subcellular test systems. Therefore, trivalent meth-
ylated arsenicals are generally believed to strongly contribute
to inorganic arsenic-induced genotoxicity and, most likely,
carcinogenicity.
Thiodimethylarsinic acid (thio-DMAV, [(CH3)2As(S)
OH], also named dimethylmonothio-arsinic acid, DMMTAV
or DMTAV) is the pentavalent sulfur analogue of DMAV and
a metabolite of organic as well as inorganic arsenicals. The
first identification of thio-DMAV as a mammalian arsenic
metabolite was obtained in urine and wool extract from a
sheep naturally consuming large amounts of arsenosugars
through seaweed [22]. In this paper, the group of Feldmann
also discussed the serious problem that thio-DMAV may
have been misidentified as DMAIII in human urine samples
before and, therefore, might have escaped detection in many
samples so far [22, 23]. Indeed, thio-DMAV has later been
identified in human urine after exposure towards arseno-
sugars as well as inorganic arsenic-contaminated drinking
water [12, 13, 23]. In a recent study investigating the arsenic
metabolites in urine samples of 75 inorganic arsenic-exposed
women in Bangladesh, thio-DMAV has been shown to be a
common metabolite, being detected in 44% of the samples
[23]. Furthermore, thio-DMAV might also directly occur in
food, which has been postulated before for rice [24].
Probably because thio-DMAV is not commercially avail-
able, in the literature no in vivo toxicity studies for thio-
DMAV (except for toxicokinetic studies) and only few in vitro
toxicity studies exist. Nevertheless, these few studies point to
a quite strong cellular toxicity of thio-DMAV in mammalian
cells in culture. Thus, in most studies, thio-DMAV showed
much higher cytotoxicity as compared to MMAV and/or
DMAV [23, 25] and comparable eﬀects to trivalent arsenicals
[26, 27]. In some studies, thio-DMAV even exerted stronger
cytotoxicity as compared to arsenite [27–29]. Moreover,
Ochi et al. provided evidence for a genotoxic potential
of thio-DMAV in cultured hamster cells [25], whereas no
detailed data exist regarding the genotoxicity of thio-DMAV
in human cells.
The aim of the present study was to further investigate
the toxicity of thio-DMAV in cultured human A549 lung
cells. Therefore, we synthesised and analytically characterised
highly pure dimethylthioarsinic anhydride, which in aque-
ous solution immediately forms thio-DMAV. Subsequently,
cytotoxicity, cellular uptake, as well as for the first time
genotoxicity at the DNA and chromosomal levels were
examined in cultured human cells, while comparing eﬀects
of thio-DMAV with eﬀects of arsenite, MMAIII, DMAIII,
MMAV, and DMAV.
2. Materials and Methods
2.1. Caution. Inorganic arsenic is classified as a human car-
cinogen. The following chemicals are hazardous and should
be handled with care: sodium arsenite, methyloxoarsine
(precursor to MMAIII), iododimethylarsine (precursor to
DMAIII), dimethylthioarsenic anhydride (precursor to thio-
DMAV), MMAV, and DMAV.
2.2.Materials. Dulbecco’s modified Eagle medium(DMEM),
foetal calf serum (FCS), trypsin, and penicillin-streptomycin
solutions were obtained from Sigma-Aldrich (Steinheim,
Germany). The culture dishes were supplied by Biochrom
(Berlin, Germany). Sodium(meta)arsenite (≥99% purity)
and Alcian Blue were purchased from Fluka Biochemika
(Buchs, Germany). Methyloxoarsine (CH3AsIIIO, ≥99%
purity) and iododimethylarsine [(CH3)2AsIIII,≥99% purity]
(storage at −80◦C) were kindly provided by Professor Dr. W.
Cullen (University of British Columbia, Vancouver, Canada).
DMAV (≥99% purity) and MMAV (99% purity) were
purchased from Sigma-Aldrich (Steinheim, Germany). A549
cells (CCL-185) were obtained from the American Type
Culture Collection (Bethesda, MD, USA).
Giemsa dye and acridine orange were bought from Roth
(Karlsruhe, Germany). The ICPMS elemental standard (As,
1mg/L) was purchased from SPETEC (Erding, Germany).
Hydrogen peroxide solution (30%, Suprapur) and nitric
acid (65%, Suprapur) were products of Merck (Darm-
stadt, Germany). Triton X-100 was bought from Pierce
(Oud-Beijerland, The Netherlands), hydroxyapatite (high
resolution) from Calbiochem (Bad Soden, Germany) and
Hoechst 33258 fromMerck (Darmstadt, Germany). All other
proanalysis chemicals were obtained from Sigma-Aldrich
(Steinheim, Germany) or Merck (Darmstadt, Germany).
2.3. Synthesis of Dimethylthioarsinic Anhydride. Dimethyl-
thioarsinic anhydride, which dissociates in water to thio-
DMAV, was synthesized according to Fricke et al. [30].
Briefly, DMAV was dissolved in ethanol (30%) and hydrogen
sulfide was bubbled into the solution and stirred over
night. After removing the solvent, the residue was extracted
with chloroform/water (3 : 1) and the chloroform layer
was washed with water to remove the remaining water-
soluble arsenic compounds. Finally, the solvent was removed
and dimethylthioarsinic anhydride was recrystallized from
methanol/hexane.
2.4. Analysis and Purity Control of Dimethylthioarsinic Anhy-
dride. HPLC-FTMS (Thermo Accela, Thermo LTQOrbitrap
XL), HPLC-ICPMS (Shimadzu LC-10, Perkin Elmer ELAN
6000), and electrothermal AAS (Perkin Elmer, AAnalyst 600)
were applied for identification and quantification as well as
to obtain information about purity of the arsenic species.
Thio-DMAV solutions in water were prepared directly for
each experiment; in order to compensate for sensitivity
diﬀerences, the sample used for HPLC-FTMS (20mg/L) was
diluted by a factor of 400 for HPLC-ICPMS analysis. Briefly,
for chromatographic separation, PTFE autosampler vials, a
reversed-phase column (Waters Atlantis T3, 2.1 × 150mm,
5 μm), and the eluent 13.2mM ammonium acetate in
water/10% methanol (pH 4.6) [30] were used. The flow rate
was 0.3mL/min. The m/z range for HPLC-FTMS analysis
was set from m/z 80 to 1000. Fragmentation experiments
were carried out with collisionally induced dissociation
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(CID) using normalized collision energy, and data analysis
was performed using Xcalibur software. For quantification
of arsenic species by HPLC-ICPMS, chromatographic data
were collected by monitoring m/z 75 (As and 40Ar35Cl)
and 77 (40Ar37Cl) with 100ms dwell time. The results of
the chromatography were analyzed with the data analysis
software from OriginLab. Quantification of total As in thio-
DMAV solutions was carried out by electrothermal AAS,
applying an ICPMS elemental standard.
Furthermore, 1H-NMR spectroscopy (Bruker DCX-400,
400MHz) was used to obtain additional purity information.
Arsenic species were dissolved in deuterium oxide (D2O),
and the chemical shift values were observed for structural
information. The obtained results were evaluated with the
NMR data software MestReNova (Mestrelab Research) and
compared with data from the literature.
2.5. Cell Culture and Incubation with the Arsenicals. Since
the lung is an important target organ for inorganic arsenic-
induced carcinogenicity, human A549 epithelial lung ade-
nocarcinoma cells were used as in vitro model system.
A549 cells were grown in culture dishes as monolayer in
DMEM containing 10% FCS, 100U penicillin/mL, and
100 μg streptomycin/mL. The cultures were incubated at
37◦C with 5% CO2 in air and 100% humidity.
Arsenical stock solutions were prepared in sterile
deionised water. All stock solutions were prepared shortly
before each experiment, among others to prevent oxidation
of trivalent arsenicals. Logarithmically growing A549 cells
were incubated with the arsenicals for 1 h or 24 h as described
for the respective experiments.
2.6. Cytotoxicity Testing of Thio-DMAV. The cytotoxicity of
thio-DMAV was elucidated by quantifying its eﬀect on cell
number and colony forming ability. Cell number and colony
forming ability testing were exactly performed as described
before for inorganic arsenic, MMAIII, DMAIII, MMAV,
and DMAV [31]. Briefly, after 24 h of incubation with
the respective arsenicals, cells were washed with phosphate
buﬀered saline (PBS) and trypsinized. Subsequently, cell
number and cell volume were measured by an automatic cell
counter (Casy-1, Roche Innovatis AG, Bielefeld, Germany).
These measurements are based on noninvasive (dye-free)
electrical current exclusion with signal evaluation via pulse
area analysis. To assess the impact of thio-DMAV on
colony forming ability of A549 cells, after cell counting of
each sample, 300 cells/dish were seeded. After 7 days of
incubation, colonies were fixed with ethanol, stained with
Giemsa (25% in ethanol), counted and calculated as percent
of control.
2.7. Cellular Bioavailability. To compare cellular bioavail-
ability of thio-DMAV with cellular bioavailability of inor-
ganic arsenic and its related methylated metabolites, cellular
bioavailability studies were carried out by exactly the same
protocol as previously reported [31]. Briefly, logarithmically
growing cells (1 ∗ 106) were exposed to thio-DMAV for
24 h, trypsinized, collected by centrifugation, washed with
ice-cold PBS, and cell number as well as cell volume were
measured by an automatic cell counter in each sample as
described before. After incubation with the ashing mixture
(65% HNO3/30% H2O2 (1/1, v/v)) at 95◦C for at least 12 h,
samples were diluted with bidistilled water, and arsenic was
measured by electrothermal atomic absorption spectrometry
(AAnalyst 600, Perkin Elmer).
2.8. Determination of DNA Strand Breaks. DNA strand
breaks were quantified by alkaline unwinding as described
previously [32]. Briefly, 1 ∗ 105 cells were seeded, allowed
to attach for 24 h and incubated with thio-DMAV for 1 or
24 h. Subsequently, the medium was removed, cells were
washed with PBS and an alkaline solution containing 0.03M
NaOH, 0.02M Na2HPO4, and 0.9M NaCl was added. After
neutralisation and sonication, separation of single- and
double-stranded DNA was performed on 0.5mL hydroxya-
patite columns at 60◦C. Single- and double-stranded DNA
were eluted with 1.5mL of 0.15M and 0.35M potassium
phosphate buﬀer, respectively. The DNA content of both
fractions was determined by adding Hoechst 33258 dye
to a final concentration of 7.5 ∗ 10−7 M to 1mL of each
sample and measuring the fluorescence with a microtiter flu-
orescence reader (FLUOstar Optima, BMG Labtechnologies,
Jena, Germany) at an excitation wavelength of 360 nm and
an emission wavelength of 455 nm. DNA strand breaks were
quantified by calibration with X-rays as described previously
[33].
2.9. Formation of Micronuclei and Multinucleated Cells. By
the early 1990s, the micronucleus assay was shown to be suit-
able to investigate arsenic-induced chromosomal alterations
as a biological marker of its genotoxicity [34]. In recent years,
the in vitro micronucleus assay has become an attractive
tool for genotoxicity testing in general [35]. Therefore, this
endpoint has been (and is) strongly used to characterize the
genotoxic potential of arsenicals in epidemiological studies
[36, 37] as well as in culturedmammalian cells (e.g., [38]). To
investigate the induction of micronuclei and multinucleated
cells, in this study A549 cells were seeded in 6-well plates on
Alcian blue coated glass coverslips. After 24 h, cells were incu-
bated with the respective arsenicals for 24 h, fixed with an
ice-cold fixation solution (90% methanol/10% PBS, −20◦C)
for 10min, dried in the air at room temperature, stained
with acridine orange (125mg/L in PBS) for 10 s, and finally
analyzed by fluorescence microscopy. Per coverslip, at least
1000 cells were counted and categorized in mononucleated,
binucleated, and multinucleated cells as well as cells with and
without micronuclei.
3. Results
3.1. Synthesis, Analysis and Purity Control of Dimethylthi-
oarsinic Anhydride. Colorless, highly pure dimethylthi-
oarsinic anhydride crystals were obtained by the reaction
of DMAV with H2S in ethanol, followed by extraction
with chloroform and recrystallisation frommethanol/hexane
(Figure 1). After dissolving dimethylthioarsinic anhydride in
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Figure 1: Scheme of the synthesis of dimethylthioarsinic anhydride and its conversion into the acid form thio-DMAV in water.
water, formation of thio-DMAV was analysed by means of
hyphenated techniques and 1H-NMR.
The mass spectrometric data and the 1H-NMR results
confirmed the conversion of the synthesized anhydride in
water into the acid form thio-DMAV. Structural elucidation
of thio-DMAV was performed by HPLC-FTMS analysis
and by determination of the exact mass. The calculated
mass of the acid form is m/z 154.9512 [M+H]+and the
detectedmass wasm/z 154.9509. Fragmentation experiments
with collisionally induced dissociation of the parent ion
m/z 154.95 [C2H8OAsS]+ gave a fragment ion of m/z
136.9403 [C2H6AsS]+ and further fragmentation led to
m/z 108.9089 [H2AsS]+. The corresponding HPLC-FTMS
total ion chromatogram (Figure 2(a)) demonstrates thio-
DMAV as a protonated molecular ion with a retention time
of 7.3min, whereas neither starting material nor further
reaction products were detected.
HPLC-ICPMS analyses further verified the purity of
thio-DMAV by retention time matching of known arsenic
species, including DMAV as the starting material. Thus,
after dissolving thio-DMAV in water, HPLC-ICPMS chro-
matograms showed only one compound (Figure 2(b)).
Under additional consideration of the quantification of thio-
DMAV by electrothermal AAS, the purity of dimethylth-
ioarsinic anhydride was assessed to be ≥98%.
1H-NMR measurements of thio-DMAV (Figure 2(c)) in
D2O resulted in a chemical shift value of 2.12 ppm which
is similar to the value of 2.11 ppm reported by Fricke et al.
[30]. DMAV showed a chemical shift of 1.98, the range of
which is consistent with a pentavalent arsenical. The 1H-
NMR data of thio-DMAV showed no impurities, and the
desired compound was obtained in analytically pure form
based on 1H-NMR spectroscopy.
3.2. Cytotoxicity of Thio-DMAV. Cytotoxicity of thio-DMAV
was determined by investigating its eﬀects on cell number
and colony forming ability (Figure 3) after 24 h incubation.
The cell volume (Figure 4) was determined as well, however,
principally to calculate cellular arsenic concentrations later
on. Regarding both endpoints, cell number and colony
forming ability, thio-DMAV exerted higher cytotoxicity as
compared to arsenite and especially to the pentavalent
methylated metabolites MMAV and DMAV, whereas eﬀects
were about twofold lower as compared to MMAIII and
DMAIII (Table 1). Thio-DMAV aﬀected colony forming abil-
ity stronger as compared to cell number, which is comparable
to the trivalent methylated metabolites. In case of arsenite,
MMAV and DMAV, both cytotoxicity endpoints showed
similar sensitivity.
Table 1: Cytotoxic eﬀects of the arsenicals in A549 cells after 24 h
incubation. Shown are IC70 values for the endpoints cell number
and colony forming ability. In case of arsenite, MMAIII, DMAIII,
MMAV, and DMAV IC70 values were generated from the data
originally published in Ebert et al. 2011 [31]; IC70 values represent
the respective inhibitory concentrations of the compounds that are
required for 30% reduction of cell number or colony forming ability
in vitro.
Arsenic species
IC70
(cell number)
IC70
(colony forming ability)
Arsenite 57.2 μM 58.8 μM
MMAIII 5.6 μM 3.8 μM
DMAIII 5.1 μM 3.2 μM
Thio-DMAV 12.1 μM 7.2 μM
MMAV >500 μM >500 μM
DMAV >500 μM >500 μM
3.3. Cellular Bioavailability of Thio-DMAV. To assess cellular
bioavailability in A549 cells and to correlate cellular toxicity
of thio-DMAV with cellular arsenic content, cellular arsenic
concentrations were determined after 24 h incubation by
electrothermal atomic absorption spectrometry.
Comparing extracellular and intracellular arsenic con-
centrations, a 9-10-fold accumulation was observed in
cells incubated with up to 15 μM thio-DMAV (Figure 4).
Thio-DMAV showed no significant eﬀects on cell volumes
(Figure 4) at noncytotoxic concentrations, but increased cell
volumes in case of cytotoxic concentrations (≥10 μM) by up
to 44%. Mean (±SD) volumes of nonincubated control cells
were 2.68 (±0.14)∗ 10−12 L.
Interestingly, the concentration of cellular arsenic
strongly correlated with the cytotoxicity of thio-DMAV,
resulting in a correlation coeﬃcient of −0.986 (cell number)
or −0.998 (colony forming ability), respectively.
3.4. Induction of DNA Strand Breaks by Thio-DMAV. A pos-
sible generation of DNA strand breaks by thio-DMAV was
investigated in A549 cells after short-term (1 h) and long-
term (24 h) incubation, applying the alkaline unwinding
technique. Up to high, already cytotoxic thio-DMAV con-
centrations both after 1 h and after 24 h incubation, no
significant induction of DNA strand breaks was observed
(Figures 5(a) and 5(b)).
3.5. Formation of Micronuclei and Multinucleated Cells by the
Arsenicals. The two basic mechanisms leading to the onset of
micronuclei are disturbance of the chromosome segregation
Journal of Toxicology 5
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Figure 3: Cytotoxicity of thio-DMAV in A549 cells after 24 h
incubation. Cytotoxicity was determined by a decrease in cell
number (closed symbols) and eﬀects on colony forming ability
(open symbols). The data represent mean values of at least six
determinations ± SD.
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Figure 4: Cellular bioavailability of arsenic in A549 cells after
24 h incubation with thio-DMAV. Logarithmically growing A549
cells were treated with thio-DMAV for 24 h, trypsinized, and cell
number as well as cell volume was determined. Finally, arsenic
was quantified by electrothermal atomic absorption spectroscopy.
Shown are mean values of at least six independent determinations
+/± SD; n.d.: below detection limit.
machinery and chromosome breakage. Thus, in somatic
cells, micronuclei can only occur after mitotic division, and
in the cytokinesis-block micronucleus assay (CBMN), which
is based on cytokinesis inhibition by cytochalasin B, cell
proliferation and thereby mitosis are generally controlled
by a scoring of mono- and binucleated cells [35]. However,
our first CBMN studies indicated that several arsenicals
interact with actin and/or the eﬀect of cytochalasin B (data
not shown). To assess the induction of micronuclei by the
arsenicals, we omitted the application of cytochalasin B. To
6 Journal of Toxicology
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Figure 5: DNA strand break formation after 1 h (a) and 24 h (b) incubation with thio-DMAV in A549 cells. DNA strand breaks were
quantified by alkaline unwinding; 5min incubation with 75 μM H2O2 served as positive control. Shown are mean values of at least six
determinations + SD.
ensure mitosis, we controlled cell proliferation by means of
cell number quantification and chose an incubation time of
24 h, which is equivalent to 1.25 cell cycles of the A549 lung
cells. This incubation time was previously used to examine
cellular toxicity of arsenicals in A549 cells [31] and, therefore,
opens the possibility to compare results. Furthermore, this
protocol allows the proper quantification of the formation of
multinucleated cells by the arsenicals at the same time.
At noncytotoxic to beginning slightly cytotoxic concen-
trations, MMAIII (0.5, 1 μM), thio-DMAV (5 μM), MMAV
(250 μM), and DMAV (250 μM) induced a small, but sig-
nificant number of around 20 micronuclei (Figure 6(a)).
At higher, already cytotoxic arsenic species concentrations,
micronuclei formation increased and became also significant
in case of arsenite (≥50 μM). At highly cytotoxic concentra-
tions, 5 μMDMAIII and 30 μM thio-DMAV showed strongest
eﬀects, inducing 188 ± 34.5 and 118 ± 4.6 micronuclei,
respectively.
Moreover, thio-DMAV and especially DMAIII increased
the formation of multinucleated cells and the occurrence of
binucleated cells in comparison to untreated control cells
(Figure 6(b)). However, significant eﬀects were restricted to
cytotoxic concentrations. For all other applied arsenicals, no
significant increased occurrence of bi- and multinucleated
cells was observed.
4. Discussion
The data presented in this study provide further evidence for
the strong cellular toxicity of the recently identified arsenic
metabolite thio-DMAV in human cells.
In the applied human lung cells, cytotoxicity of thio-
DMAV strongly correlates with its cellular bioavailability. For
other arsenic species, a similar correlation has been reported
in A549 cells [31] as well as in human urothelial (UROtsa)
and hepatic (HepG2) cells [39] before.
When comparing the respective arsenic incubation
concentrations, thio-DMAV exerts higher cytotoxicity than
arsenite, whereas eﬀects are lower as compared to MMAIII
and DMAIII. When additionally taking into account the
cellular bioavailability of the arsenicals, among all arsenicals,
applied thio-DMAV shows the highest cytotoxicity in A549
cells. For instance, 30% reduction in cell number occurred
after 24 h incubation with 5 μM DMAIII, which is related
to 237 ± 38.2μM cellular arsenic [31]. 12.1 μM thio-DMAV
caused a similar reduction in cell number; however, it
corresponds to a cellular arsenic concentration of 115 ±
9.4μM. Thus, a similar cytotoxic eﬀect is achieved at twofold
lower cellular arsenic concentrations. In summary, referring
to the extracellular incubation concentrations, in A549
human lung cells the arsenicals follow the cytotoxic order:
DMAIII > MMAIII > thio-DMAV  arsenite  MMAV ∼
DMAV. Taking into account the cellular uptake of the
arsenic species and thereby referring to the eﬀective cellular
arsenic concentrations, the cytotoxic order switches to thio-
DMAV ∼ arsenite ∼MMAIII >DMAIII MMAV ∼DMAV.
This is somehow contrary to the study by Naranmandura et
al. [26], where at the respective IC50 concentrations, cellular
thio-DMAV uptake was higher as compared to DMAIII and
arsenite uptake. This diﬀerent outcome might be due to
the diﬀerent cell systems applied, but most likely results
from the diﬀerent cytotoxicity endpoints investigated. By
using the MTT test, Naranmandura et al. used a cellular
metabolism-related cytotoxicity endpoint, which quantifies
the impact of the arsenicals on the activity of cellular dehy-
drogenases. In contrast, in this study we quantified cell num-
ber, which comprises cell death and proliferation inhibition
by the arsenicals. Moreover, colony forming ability, which
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Figure 6: Induction of micronuclei (a), binucleated and multinucleated cells (b) after 24 h incubation of A549 cells. After 24 h in culture,
logarithmically growing A549 cells were treated with arsenite, MMAIII, DMAIII, thio-DMAV, MMAV, or DMAV for 24 h; cells were fixed,
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micronuclei level in control was 27 ± 3; (a, b): shown are mean values of at least three independent determinations + SD; statistically
significant diﬀerent from nonarsenic exposed controls: ∗P < 0.01 as determined by Student’s t-test.
is generally considered as benchmark long term-cytotoxicity
assay for directly not acute cytotoxic compounds, was
applied as second cytotoxicity endpoint. Very interestingly,
thio-DMAV exerts stronger cytotoxicity regarding the end-
point colony forming ability, which points to an indirect
mode of toxic action. This has similarly been shown before
for the trivalent methylated metabolites [31].
In contrast to all other methylated arsenic metabolites
[18], in A549 cells thio-DMAV showed no generation of
DNA strand breaks up to high cytotoxic concentrations.
This is also in line with the fact that thio-DMAV did not
significantly increase reactive oxygen species level in A549
cells (as assessed by DCFDA fluorescence) up to high cyto-
toxic concentrations (data not shown). This is in contrast to
the postulated, reactive oxygen species-mediated toxic mode
of action of thio-DMAV [28, 40]. Accordingly thio-DMAV,
as well as DMAIII and arsenite, exerted strong genotoxicity
on the chromosomal level only at cytotoxic concentrations.
Thus, in the present study, MMAIII is the only arsenical-
inducing micronuclei at noncytotoxic, exposure-relevant
concentrations starting at 0.5 μM. Micronuclei formation in
A549 cells results at least partly from the earlier observed
induction of DNA damage by 0.5 μM MMAIII [18].
For DMAIII, micronuclei induction has been shown
before in CHO cells [38] and is discussed to be due to
both aneugenic and clastogenic eﬀects of DMAIII. In SHE
(Syrian hamster embryo) cells after 24 h incubation, 20 μM
thio-DMAV induced chromosome structural aberrations
including chromatid gaps, chromatid break and chromatid
changes [25]. This fits nicely to earlier data by Kuroda et al. in
V79 Chinese hamster lung cells: here, the unknownmicrobial
metabolite of DMAV, which is nowadays strongly discussed
to be thio-DMAV, induced chromosomal aberrations as well
as sister chromatid exchange, mitotic arrest, and tetraploids
[41]. In this study, thio-DMAV and especially DMAIII ad-
ditionally increased the formation of multinucleated and
binucleated cells, which most probably results from spindle
abnormalities induced by these arsenic species [25, 42].
Furthermore, the increased formation of binucleated cells
indicates an inhibitory eﬀect of DMAIII and thio-DMAV on
cytokinesis. Accordingly, in the same concentration range,
both arsenicals caused a G2/M cell cycle phase arrest after
24 h incubation in A549 cells (data not shown). For thio-
DMA, this has already been shown before in human HepG2
hepatocarcinoma cells [25] and A431 epidermoid carcinoma
cells [26].
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When rating the formation of micronuclei, micronu-
cleated and binucleated cells, it once again has to be
clearly stated that all these eﬀects were restricted to
high concentrations of arsenite, thio-DMAV, and DMAIII.
Strong eﬀects were observed exclusively for DMAIII, with
a sevenfold increase in micronuclei induction, a tenfold
increased occurrence of binucleated cells, and an 80-fold
increase in multinucleated cells after 24 h incubation with
5 μM DMAIII. Thus, in case of DMAIII, these eﬀects most
likely trigger DMAIII cytotoxicity, especially regarding the
endpoint colony forming ability. This is unlikely for thio-
DMAV and even more unlikely for arsenite.
In summary, thio-DMAV seems to exert its high cellular
toxicity by a diﬀerent mode of action than arsenite, MMAIII,
and DMAIII. Our data strongly indicate that in human A549
lung cells, thio-DMAV does not act via a genotoxic mode
of action. Nevertheless, to assess the role of thio-DMAV in
inorganic arsenic-induced carcinogenicity, to date still too
little is known about thio-DMAV. This is particularly valid
as thio-DMAV is a human metabolite not only of inor-
ganic arsenic but also of seafood related organic arsenicals,
which indicates that further mechanistic studies are urgently
needed to identify its toxic mode of action and finally assess
the potential implications for human health.
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